拜阿司匹林、氯吡格雷与低分子肝素钠三联治疗急性ST段抬高型心肌梗死30例临床疗效

目的观察急性ST段抬高型心肌梗死应用拜阿司匹林、氯吡格雷与低分子肝素三联治疗的临床疗效。方法将60例急性ST段抬高型心肌梗死患者随机均分为两组，对照组（拜阿司匹林和低分子肝素钠治疗）、治疗组（拜阿司匹林、氯吡格雷与低分子肝素钠三联治疗），观察两组的临床疗效。结果治疗组治疗前后心绞痛复发次数减少百分比明显大于对照组，治疗组的总出血率明显小于对照组，差异均有统计学意义（P〈0．05）。结论急性ST段抬高型心肌梗死应用拜阿司匹林、氯吡格雷与低分子肝素司三联治疗疗效较好，值得更广泛地应用。

Clinical curative effect of aspirin,clopidogrel and the low molecular heparin joint in treatment of 30 cases with acute ST segment elevation myocardial infarction

Objective To observe the clinical curative effect of aspirin,clopidogrel and the low molecular heparin in treatment of acute ST segment elevation myocardial infarction. Methods Sixty patients with acute ST segment elevation myocardial infarction patients were randomly divided into two groups ,control group（worship of aspirin and the low molecular heparin treatment）,the treatment group （aspirin, clopidogrel and low molecular heparin therapy）, compare the clinical efficacy of the two groups. Results Before and after the treatment angina recurrence rate reduction percentage mean project in treatment group were better than the control group, the bleeding rate in treatment group were less than the control group,and the differences two groups of two indexes have statistical significance （P 〈 0.05）. Conclusion Aspirin and elopidogrel and low molecular heparin in treatment of acute ST segment elevation myocardial infarction clinical curative effect is good, is more widely used.